Global Intravenous Solutions Market Poised for Substantial Growth, Projected to Reach $26.55 Billion by 2031
The global intravenous (IV) solutions market is set for remarkable expansion, driven by the escalating prevalence of chronic diseases, a burgeoning geriatric population, and the increasing adoption of home healthcare. A recent comprehensive analysis reveals that the market, valued at $12.16 billion in 2021, is anticipated to surge to $26.55 billion by 2031 , exhibiting a robust Compound Annual Growth Rate (CAGR) of 8.3% from 2022 to 2031. This significant growth trajectory underscores the indispensable role of IV solutions in modern medical care, from emergency interventions to long-term patient management. Get All Details: https://www.alliedmarketresearch.com/intravenous-solutions-market-A17078 Intravenous solutions are sterile preparations administered directly into a patient’s vein, playing a critical role in fluid and electrolyte balance, medication delivery, and nutritional support. They are fundamental to patient care across virtually all healthcare settings, ensuring hydra...